抑制因子HIF (FIH) 促进肺癌的进展
Ana García-Del Río1, Endika Prieto-Fernández1, Leire Egia-Mendikute1
1Cancer Immunology and Immunotherapy Lab, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Bizkaia, Spain.
抑制因子HIF (FIH) 是细胞适应低氧的关键调节者. 抑制肺癌细胞中的FIH减少了瘤生长和转移,这表明FIH是非小细胞肺癌 (NSCLC) 的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 抑制因子HIF (FIH) 是一种阿斯巴拉金氧酶,调节低氧诱导因子 (HIFs) 以使细胞适应低氧.
- 在各种瘤中检测到FIH表达,但其在瘤进展中的作用尚未完全理解.
研究的目的:
- 研究FIH对肺癌进展的影响及其作为治疗点的潜力.
主要方法:
- 在人类和小鼠肺癌细胞中删除FIH.
- 对细胞代谢,增殖,RNA-Seq和免疫细胞透的分析.
- 在小鼠体内瘤生长和转移研究.
- 对FIH表达与患者生存数据的相关性分析.
主要成果:
- 删除FIH增加了糖溶性代谢和HIF活性,同时降低了肺癌细胞的增殖.
- 缺少FIH导致细胞循环的失调,生存途径,以及血管新生素 (Amot) 的上调.
- 缺乏FIH的瘤显示NK和T细胞透增加,瘤生长减少,转移能力降低.
- 高FIH表达与非小细胞肺癌 (NSCLC) 患者的整体生存率差相关.
结论:
- FIH在肺癌的进展中发挥着重要作用,促进了扩散,免疫逃避和转移.
- 针对FIH代表了治疗肺癌,特别是NSCLC的有前途的治疗策略.
更多相关视频
07:39The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
相关概念视频
Regulation of Angiogenesis and Blood Supply
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cancer Prevention
Some...
